J&J and Roche Lead in S&P Ratings for Pharmaceutical Companies J&J and Roche Lead in S&P Ratings for Pharmaceutical Companies

Photo of author

By Ronald Tech

he modern architecture of business center of Johnson and Johnson, Allschwil

Johnson & Johnson (NYSE:JNJ) and Roche (OTCQX:RHHBY) have emerged as the cream of the crop among pharmaceutical giants, boasting the lowest business and financial risks based on a recent S&P Global report.

These juggernauts, J&J and Roche, excelled in terms of magnitude and blockbuster medications compared to their industry peers.


See also  The Boeing Conundrum: Navigating Wall Street Analyst Optimism